Browse studies

Find your next paid study

56 recruiting studies matching your filters

Gene Expression Changes in Young and Geriatric Skin

This study does not involve any particular diagnosis. The goal of this research study is to explore the effects of artificial sunlight (ultraviolet B radiation…

UVB Phototherapy BurnInsulin-like Growth Factor 1Aging

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Wright State UniversityNCT03932162

Observational

Targeted Fortification of Donor Breast Milk in Preterm Infants

This study is a randomized controlled trial comparing standard fortification of donor breast milk to targeted fortification of donor breast milk in preterm inf…

Prematurity; ExtremeFailure to Thrive in NewbornGrowth Retardation+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Columbia UniversityNCT04294368

A Multi-national, Multi-centre, Prospective, Single-arm, Observational, Non-interventional Post-authorisation Safety Study to Investigate Long-term Safety of Sogroya® (Somapacitan) in Adults With Growth Hormone Deficiency (AGHD) Under Routine Clinical Practice

In this study, the general long-term safety and effectiveness of Sogroya (somapacitan) in adults with growth hormone deficiency (AGHD) being treated per normal…

Adult Growth Hormone Deficiency

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Novo Nordisk A/SNCT05718570

3-Dimensional Optical Scanning to Assess and Monitor Malnutrition in Eating Disorders (3D-ED) Study

People with anorexia nervosa often become medically unstable because of severe malnutrition and require hospitalization for nutritional rehabilitation. Clinici…

Anorexia in AdolescenceAnorexia NervosaAnorexia Nervosa, Atypical+7 more

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT07726524

Identification of Biomarkers for Patients with Vascular Anomalies

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest pr…

Vascular AnomalyGeneralized Lymphatic AnomalyKaposiform Hemangioendothelioma+4 more

Estimated

~$10 – $675

Actual pay is set by the research site.

Children's Hospital Medical Center, CincinnatiNCT03001180

Phase 1

A First-in-Human, Open-label, Multicenter, Phase 1 Study of EPI-326 in Patients With Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma

A phase 1 study to determine the safety, tolerability, PK, PD, and preliminary anti-tumor activity of ascending doses of EPI-326 administered to patients with …

Epidermal Growth FactorEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Gene Mutation+12 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Phase 1

Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma

Testing an investigational cancer therapy called TGFBR-2 KO CD70 CAR NK cell therapy.

Clear Cell CarcinomaPhase 1Growth Factor

Estimated

~$150 – $3,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07072234

A US Multi-center, Prospective, Non-interventional, Long Term, Effectiveness and Safety Study of Patients Treated With SKYTROFA (Lonapegsomatropin)

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency …

Growth Hormone Deficiency

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Ascendis Pharma Endocrinology Division A/SNCT05820672

Familial Investigations of Childhood Cancer Predisposition

NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may recei…

Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more

Estimated

~$10 – $750

Phase 2

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation

This is a 3-part Phase 2 randomized study evaluating the safety and efficacy of the mutant-selective PI3Kα inhibitor, zovegalisib (RLY-2608), in adults and chi…

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Relay Therapeutics, Inc.NCT06789913

Observational

Growth and Tolerance of Preterm Infants Fed an Experimental Human Milk Fortifier

This is a double-blind, randomized, multi-center, controlled, parallel study to evaluate the growth and tolerance of preterm infants fed human milk fortifier (…

Growth

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Abbott NutritionNCT05551975

The Chromosome 18 Clinical Research Center

Our vision, that of the researchers at the University of Texas Health Science Center at San Antonio, is that every person with a chromosome 18 abnormality will…

Chromosome AberrationsGrowth Hormone DeficiencyHypomyelination

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Texas Health Science Center at San AntonioNCT00227253